Patents by Inventor Naofumi Takamatsu

Naofumi Takamatsu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antibodies that specifically bind to A beta oligomers and use thereof
    Patent number: 9090679
    Abstract: The present inventors successfully produced monoclonal antibodies that are specific to only soluble A beta oligomers, but do not recognize soluble A beta monomers, which are physiological molecules. It was demonstrated that the antibodies are useful as diagnostic/therapeutic monoclonal antibodies for Alzheimer's disease.
    Type: Grant
    Filed: April 16, 2010
    Date of Patent: July 28, 2015
    Assignee: Immunas Pharma, Inc.
    Inventors: Tatsuki Yokoseki, Yasuhide Okamoto, Makoto Umeda, Toshiyuki Ito, Yukiho Imai, Shinobu Fujii, Naofumi Takamatsu
  • Antibodies that specifically bind to a beta oligomers and use thereof
    Patent number: 8858949
    Abstract: The present inventors successfully produced monoclonal antibodies that are specific to only soluble A beta oligomers, but do not recognize soluble A beta monomers, which are physiological molecules. It was demonstrated that the antibodies are useful as diagnostic/therapeutic monoclonal antibodies for Alzheimer's disease.
    Type: Grant
    Filed: August 5, 2010
    Date of Patent: October 14, 2014
    Assignee: Immunas Pharma, Inc.
    Inventors: Tatsuki Yokoseki, Yasuhide Okamoto, Makoto Umeda, Naofumi Takamatsu, Toshiyuki Ito, Yukiho Imai, Shinobu Fujii
  • Antibodies that specifically bind to A beta oligomers and use thereof
    Patent number: 8613924
    Abstract: The present inventors successfully produced monoclonal antibodies that are specific to only soluble A beta oligomers, but do not recognize soluble A beta monomers, which are physiological molecules. It was demonstrated that the anti-bodies are useful as diagnostic/therapeutic monoclonal antibodies for Alzheimer's disease.
    Type: Grant
    Filed: August 5, 2010
    Date of Patent: December 24, 2013
    Assignee: Immunas Pharma, Inc.
    Inventors: Tatsuki Yokoseki, Yasuhide Okamoto, Makoto Umeda, Naofumi Takamatsu, Toshiyuki Ito, Yukiho Imai, Shinobu Fujii
  • Antibodies That Specifically Bind to A Beta Oligomers and Use Thereof
    Publication number: 20120177664
    Abstract: The present inventors successfully produced monoclonal antibodies that are specific to only soluble A beta oligomers, but do not recognize soluble A beta monomers, which are physiological molecules. It was demonstrated that the antibodies are useful as diagnostic/therapeutic monoclonal antibodies for Alzheimer's disease.
    Type: Application
    Filed: August 5, 2010
    Publication date: July 12, 2012
    Applicant: Immunas Pharma, Inc.
    Inventors: Tatsuki Yokoseki, Yasuhide Okamoto, Makoto Umeda, Naofumi Takamatsu, Toshiyuki Ito, Yukiho Imai, Shinobu Fujii
  • Antibodies That Specifically Bind to A Beta Oligomers and Use Thereof
    Publication number: 20120156193
    Abstract: The present inventors successfully produced monoclonal antibodies that are specific to only soluble A beta oligomers, but do not recognize soluble A beta monomers, which are physiological molecules. It was demonstrated that the anti-bodies are useful as diagnostic/therapeutic monoclonal antibodies for Alzheimer's disease.
    Type: Application
    Filed: August 5, 2010
    Publication date: June 21, 2012
    Applicant: IMMUNAS PHARMA, INC.
    Inventors: Tatsuki Yokoseki, Yasuhide Okamoto, Makoto Umeda, Naofumi Takamatsu, Toshiyuki Ito, Yukiho Imai, Shinobu Fujii
  • Antibodies That Specifically Bind To A Beta Oligomers And Use Thereof
    Publication number: 20120082667
    Abstract: The present inventors successfully produced monoclonal antibodies that are specific to only soluble A beta oligomers, but do not recognize soluble A beta monomers, which are physiological molecules. It was demonstrated that the antibodies are useful as diagnostic/therapeutic monoclonal antibodies for Alzheimer's disease.
    Type: Application
    Filed: April 16, 2010
    Publication date: April 5, 2012
    Applicant: IMMUNAS PHARMA, INC.
    Inventors: Tatsuki Yokoseki, Yasuhide Okamoto, Makoto Umeda, Toshiyuki Ito, Yukiho Imai, Shinobu Fujii, Naofumi Takamatsu